545.53
price up icon0.55%   3.01
after-market アフターアワーズ: 545.53
loading

Regeneron Pharmaceuticals Inc (REGN) 最新ニュース

pulisher
12:18 PM

Evergreen Wealth Management LLC Invests $3.59 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

12:18 PM
pulisher
09:39 AM

Neutralizing Antibody Market Surges with Monoclonal Therapy & - openPR.com

09:39 AM
pulisher
06:39 AM

South Dakota Investment Council Buys New Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

06:39 AM
pulisher
06:01 AM

Private Advisor Group LLC Purchases 1,957 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

06:01 AM
pulisher
Jul 20, 2025

What analysts say about Regeneron Pharmaceuticals Inc. stockSuperior trading gains - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Regeneron Pharmaceuticals Inc. Stock Analysis and ForecastDynamic investment growth - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Is Regeneron Pharmaceuticals Inc. a good long term investmentHigh-yield growth strategies - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Morse Asset Management Inc Has $2.61 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Regeneron Pharmaceuticals Inc. stock priceMarket-crushing profits - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

678 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by AustralianSuper Pty Ltd - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

Massachusetts Financial Services Co. MA Has $13.30 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

Apollon Wealth Management LLC Boosts Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 20, 2025
pulisher
Jul 19, 2025

Regeneron Pharmaceuticals Stock: Is Wall Street Bullish or Bearish? - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

Edgestream Partners L.P. Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

Balentine LLC Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

Victory Capital Management Inc. Sells 42,722 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Sumitomo Life Insurance Co. - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead. - The Motley Fool

Jul 19, 2025
pulisher
Jul 19, 2025

Cwm LLC Increases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 19, 2025
pulisher
Jul 18, 2025

Regeneron’s New Study on Anticoagulant Alternatives: A Potential Game Changer? - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Regeneron’s Promising Phase 3 Trial for Follicular Lymphoma: A Potential Game-Changer? - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Regeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold? - The Globe and Mail

Jul 18, 2025
pulisher
Jul 18, 2025

Bailard Inc. Trims Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 18, 2025
pulisher
Jul 18, 2025

Does Regeneron Pharmaceuticals (NASDAQ:REGN) Have A Healthy Balance Sheet? - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

Wealthfront Advisers LLC Sells 1,173 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 18, 2025
pulisher
Jul 18, 2025

Las bolsas europeas suben, con el foco en los resultados - Yahoo Finanzas

Jul 18, 2025
pulisher
Jul 18, 2025

47,567 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat

Jul 18, 2025
pulisher
Jul 17, 2025

Cutter & CO Brokerage Inc. Raises Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 17, 2025
pulisher
Jul 17, 2025

Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game-Changer for Chronic Rhinosinusitis - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Market Game-Changer? - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Regeneron’s Promising Obesity Treatment Study: A Potential Game-Changer? - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Red Biotechnology Market Attracts Investments from Major - openPR.com

Jul 17, 2025
pulisher
Jul 17, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Boosted by Concord Wealth Partners - MarketBeat

Jul 17, 2025
pulisher
Jul 17, 2025

Cullen Frost Bankers Inc. Has $4.36 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 17, 2025
pulisher
Jul 17, 2025

Asahi Life Asset Management CO. LTD. Makes New $434,000 Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 17, 2025
pulisher
Jul 17, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Arizona State Retirement System - MarketBeat

Jul 17, 2025
pulisher
Jul 16, 2025

UBS Raises Regeneron (REGN) Price Target, Maintains Neutral Rating - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

Regeneron’s Innovative Approach in Follicular Lymphoma Treatment: A New Phase 3 Trial - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

Retinal Vein Occlusion Market Trends: Surge in Anti-VEGF - openPR.com

Jul 16, 2025
pulisher
Jul 16, 2025

Grandfield & Dodd LLC Acquires 611 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 16, 2025
pulisher
Jul 16, 2025

Unexpected Trends Reshaping the Diabetic Retinopathy Market - openPR.com

Jul 16, 2025
pulisher
Jul 15, 2025

Regeneron and Intellia’s Gene Therapy Study: A Potential Game-Changer for Hemophilia B - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

CenterBook Partners LP Sells 10,270 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 15, 2025
pulisher
Jul 15, 2025

Concord Asset Management LLC VA Has $1.33 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 15, 2025
$320.52
price down icon 0.00%
$566.14
price up icon 0.27%
biotechnology ONC
$291.93
price down icon 0.89%
$108.91
price down icon 1.01%
$26.34
price up icon 0.53%
大文字化:     |  ボリューム (24 時間):